Skip to content

FNY

GradeCNASDAQ

First Trust Mid Cap Growth AlphaDEX Fund

Broad Stock Market · First Trust · Inception 2011-04-19 · SEC filings

$99.84−1.11 (−1.10%)

As of Sep 23, 2026, 2:20 PM EDT

Intraday session: down, 59 prints from 100.95 to 99.84. Range 99.60 to 101.04. Use the arrow keys to read each point.$99.50$100.50$101.0010 AM12 PM2 PM4 PM
Expense ratio
0.73%
Fund size
$568M
1Y return
+9.5%
Yield · Last 12 months
0.00%
Holdings
224
Volume · 30D
0M sh
NAV per share
$100.48
52W range
low $85.09high $111.06

The ETF.net FNY Grade

C

41/ 100

Rank 12 of 13 in US Mid-Cap

Confidence High

Six-pillar profile for FNY. Scores out of 100: Cost 10, Risk 16, Mission 80, Tradability 57, Holdings 53, Durability 56. Strongest: Mission (80). Weakest: Cost (10). Leans toward Mission.
F< 25
D≥ 25
C≥ 40
B≥ 55
A≥ 70

Score 41 of 100 sits in the C band. Bands: A ≥ 70, B ≥ 55, C ≥ 40, D ≥ 25, F < 25; the scale skips E.

  • Cost

    What you pay to own it — the expense ratio plus trading frictions, ranked within its category.
    FScore 10
    Category rank12/13 · bottom quartile
  • Mission

    How faithfully it does the job it claims — tracking its mandate or index with minimal slippage.
    AScore 80
    Category rank10/11 · bottom quartile
  • Risk

    How violently it can move — volatility, drawdown depth, and downside capture versus its category.
    FScore 16
    Category rank13/13 · bottom quartile
  • Tradability

    How cheaply and easily you can get in and out — liquidity, spread, and premium/discount stability.
    BScore 57
    Category rank7/13 · mid-pack
  • Holdings

    What it actually owns — the quality, breadth, and concentration of the underlying portfolio.
    CScore 53
    Category rank9/13 · mid-pack
  • Durability

    Whether it will still be here — the fund’s assets, age, flows, and issuer staying power.
    BScore 56
    Category rank6/13 · top 46%

Graded as of Sep 22, 2026

Our read on FNY

ETF.net Research

CMost mid-cap funds just own the market. FNY runs Nasdaq's AlphaDEX screen instead: rank mid-cap growth names, cut the weakest, weight by score rather than size. A quant stock-picker in index clothing.

Stated mandate

The Fund seeks to track, before fees and expenses, the price and yield performance of the Nasdaq AlphaDEX Mid Cap Growth Index. It uses an indexing approach, normally investing at least 90% of net assets in securities comprising that index.

Why people hold it

  1. 01AlphaDEX scores mid-cap names on growth and value measures, drops the low scorers, then weights survivors by rank, not market cap. Deliberately different from a cap-weighted index.ftportfolios.com
  2. 02Spreads the bet across roughly 200-plus mid-cap stocks, with at least 90% of net assets in index constituents.
  3. 03Trading since 2011, so this screen has a long public record across several market cycles.

Worth knowing

  1. 01At 0.73% a year the fee sits well above the mid-cap peer median near 0.15%; cap-weighted rivals VO and SCHM charge 0.03%. The screen has that hurdle to clear.
  2. 02Thinly traded next to the mid-cap giants, so bid-ask spreads and order slippage matter more here.
  3. 03Rank weighting tilts toward smaller, higher-momentum names, so results can diverge widely from a standard mid-cap index, in either direction.ftportfolios.com

FNY Holdings

As of Sep 21, 2026, 5:07 PM
Asset class
Stocks
Holdings
224
Top-10 weight
9%
Largest holding
ZETA1.0%

Sectors

  • Health Care22.9%
  • Industrials20.1%
  • Technology19.1%
  • Consumer Discr.13.7%
  • Financials9.6%
  • Real Estate6.3%
  • Cons. Staples2.7%
  • Communication2.5%
  • Materials1.5%
  • Energy1.4%
  • Utilities0.3%

Geography

  • United States99.27%
  • United Kingdom0.55%
  • Ireland0.18%
The fund’s holdings, weight-ordered — page 1 of 15.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001ZETAZeta Global Holdings Corp. (Class A)1.01%187,834$6M95
002GHGuardant Health, Inc.0.98%30,799$6M171
003HALOHalozyme Therapeutics, Inc.0.94%47,228$5M200
004AMRXAmneal Pharmaceuticals, Inc.0.89%266,938$5M129
005OKTAOkta, Inc.0.88%27,091$5M245
006TGTXTG Therapeutics, Inc.0.85%84,104$5M129
007TPCTutor Perini Corporation0.84%55,691$5M131
008CORTCorcept Therapeutics Inc.0.83%42,514$5M147
009FTDRFrontdoor, Inc.0.83%59,553$5M140
010COKECoca-Cola Consolidated, Inc.0.83%24,202$5M181
011MSGSMadison Square Garden Sports Corp. (Class A)0.82%11,499$5M111
012PACSPACS Group, Inc.0.81%108,366$5M100
013IBRXImmunityBio, Inc.0.80%527,779$4M74
014ETSYEtsy, Inc.0.79%61,340$4M175
015GKOSGlaukos Corporation0.77%26,450$4M123

Showing 1–15 of 225 holdings

FNY Performance

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

FNY$10,946
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$11,723
Sep 22, 2025 to Sep 22, 2026. FNY $10,946. SPY $11,723. Use the arrow keys to read each point.$9,204$10,716$12,227Sep 2025Mar 2026Sep 2026

Sep 22, 2025 – Sep 22, 2026

Returns run to the Sep 22, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for FNY. Periods over one year show the average yearly return.
PeriodFNY
Year to date+10.7%
1 month−3.9%
3 months−7.2%
1 year+9.5%
3 years+19.1%per year
5 years+6.4%per year
10 years+12.7%per year

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for FNY
YearReturn barFNY
2026 YTD+10.7%
2025+14.0%
2024+18.1%
2023+21.1%
2022−23.8%
2021+13.5%
2020+37.0%

FNY in the news

ETF.net Research hasn’t filed on FNY yet — coverage lands here as it’s written.

FNY Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Sep 22, 2026.
0.00%Last 12 months
Payout per share
NoneLast 12 months

No distributions in the last 12 months.

Distribution history

Payments through 2025

One bar per payment. 21 payments from 2016 to 2025. Mar 23, 2016 $0.02; Jun 22, 2016 $0.03; Sep 21, 2016 $0.03; Dec 21, 2016 $0.12; Jun 22, 2017 $0.03; Sep 21, 2017 $0.007; Dec 21, 2017 $0.05; Dec 18, 2018 $0.02; Sep 25, 2019 $0.02; Dec 13, 2019 $0.11; Mar 26, 2020 $0.004; Sep 24, 2020 $0.09; Dec 24, 2020 $0.07; Sep 23, 2022 $0.02; Dec 23, 2022 $0.11; Mar 24, 2023 $0.08; Jun 27, 2023 $0.02; Dec 22, 2023 $0.06; Sep 26, 2024 $0.31; Dec 13, 2024 $0.14; Jun 26, 2025 $0.03. Use the arrow keys to read each point.2016201720182019202020212022202320242025
Ex-datePay dateAmount per share
Jun 26, 2025Jun 30, 2025$0.03
Dec 13, 2024Dec 31, 2024$0.14
Sep 26, 2024Sep 30, 2024$0.31
Dec 22, 2023Dec 29, 2023$0.06
Jun 27, 2023Jun 30, 2023$0.02
Mar 24, 2023Mar 31, 2023$0.08
Dec 23, 2022Dec 30, 2022$0.11
Sep 23, 2022Sep 30, 2022$0.02
Dec 24, 2020Dec 31, 2020$0.07
Sep 24, 2020Sep 30, 2020$0.09
Mar 26, 2020Mar 31, 2020$0.004
Dec 13, 2019Dec 31, 2019$0.11

FNY Risk

How much the fund’s monthly returns vary, scaled to a year.
19.7%
Annualised · 36 months to Aug 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.67
vs 3-month T-bills · to Aug 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−33.9%
Trough Sep 2022
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
1.19
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

FNY Cost

Expense ratio0.73%
  • The middle half of US Mid-Cap funds
  • Median 0.15%

11 of the 13 US Mid-Cap funds charge less.

FNY costs $73.00 a year on $10,000. The median US Mid-Cap fund costs $15.00.